The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 135.00
Bid: 134.00
Ask: 136.00
Change: 0.00 (0.00%)
Spread: 2.00 (1.493%)
Open: 135.00
High: 135.00
Low: 135.00
Prev. Close: 135.00
ECEL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CEO Announces Intention to Retire in 2023

6 Jan 2023 07:00

RNS Number : 8666L
Eurocell plc
06 January 2023
 

6 January 2023

EUROCELL PLC

("Eurocell" or the "Group")

 

CEO Announces Intention to Retire in 2023 and CEO Designate Appointed

 

Eurocell, the market leading, vertically integrated UK manufacturer, distributor and recycler of innovative window, door and roofline PVC building products, announces that Mark Kelly, Chief Executive Officer, has notified the Board of his intention to retire later this year. He will be succeeded as CEO by Darren Waters, currently Chief Operating Officer of Ibstock plc, who will join the Board of Eurocell as Chief Executive Designate this spring.

 

Mark has led the Group successfully from 2016, overseeing positive change throughout the business, delivering on significant growth since then, as well as completing substantial investment to expand capacity and provide a strong platform for the future. To ensure a smooth transition, Mark will remain in his role until a handover period has been completed, following which he will step down from the Board and the position of Chief Executive at the Group's AGM in May.

 

Darren has extensive experience and knowledge of the building products and fenestration sectors in the UK, both from his current role at Ibstock and from his previous position at Tyman plc, where he was the Chief Executive of UK and Ireland from 2012 to 2020. Prior to Tyman, Darren held senior management roles at Kenda Capital BV, Anglo American plc and RMC Group plc.

Derek Mapp, Chair of the Board, said:

"As Chief Executive, Mark has been instrumental in Eurocell's success and development as a new plc. He has led the Group through a period of very strong growth and navigated the exceptional challenge of the COVID pandemic. We are extremely grateful to Mark for his immense contribution to the Group and his commitment to ensure a smooth transition. On behalf of the Board, I thank him for his significant achievements and we wish him all the very best for the future.

 

"I am absolutely delighted that we have secured someone of Darren's calibre. He brings a wealth of commercial and operational experience and the Board and I are looking forward to working with him to lead Eurocell through the next stage of our development."

 

Mark Kelly, Chief Executive Officer, said:

"It has been a privilege to lead Eurocell through an exciting period of change, investment and growth. The business is now well placed, with the capacity both to take advantage of market conditions as they develop within the UK building products sector and further improve efficiency. Darren will be joining a great team who will support him as he drives the business forward. I would like to thank all my colleagues for their support and look forward to watching Eurocell continue to grow and prosper in the years ahead."

 

We intend to publish our usual year end trading update on 26 January 2023.

 

This announcement is made pursuant to LR 9.6.11R of the Listing Rules and there are no further matters, required by paragraphs 9.6.13R (1) to (6) of the Listing Rules, to be disclosed in relation to Darren Waters.

 

 

 

Enquiries:

Eurocell plc

Mark Kelly, Chief Executive Officer

+44 (0) 1773 842 105

Michael Scott, Chief Financial Officer

+44 (0) 1773 842 140

Teneo

Ben Foster

+44 (0) 777 624 0806

Camilla Cunningham

+44 (0) 746 498 2426

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASSFFAIEDSEDF
Date   Source Headline
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 20247:00 amRNSTransaction in Own Shares
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSDirector/PDMR Shareholding
19th Apr 20247:00 amRNSPublication of 2023 Annual Report & Notice of AGM
19th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:01 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSDirector/PDMR Shareholding
26th Mar 20244:30 pmRNSHolding(s) in Company
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSInvestor Presentation
20th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSBlock listing Interim Review
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSTransaction in Own Shares
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20246:00 pmRNSHolding(s) in Company
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSDirector/PDMR Shareholding
13th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.